Open Access Open Access  Restricted Access Subscription or Fee Access

Chronic Fatigue Syndrome

N. Guna, B. Sangameswaran, P. Sutha, T. Sudhamani, K. Kathikeyan

Abstract


Chronic fatigue syndrome (CFS) is a multisystemic dysfunctional illness that is characterized by long-term disabling fatigue that is at least 6 months in duration and is accompanied by a variety of rheumatologic, infectious, neuropsychiatric, and neurological symptoms. CFS patients have a significantly impaired functional status that leads to significant personal and economic complications. The purpose of this review was to determine if CBT is more successful than other treatments for CFS and whether it works for CBT both on its own and in conjunction with other therapies. The review also examined the effectiveness of CBT in comparison to other psychological therapy modalities, such as counseling, support/education, and relaxation techniques. It concluded that patients receiving CBT had a higher likelihood of experiencing fewer symptoms of fatigue at the conclusion of their treatment than patients receiving other psychological therapies. There was also a greater reduction in symptoms related to psychological distress, anxiety, depression, and physical functioning. The most compelling and reliable result is that those with CFS have greater rates of mental co-morbidity than healthy controls or disease control groups, primarily for anxiety and depressive disorders.

Chronic fatigue syndrome (CFS) is a multisystemic dysfunctional illness that is characterized by long-term disabling fatigue that is at least 6 months in duration and is accompanied by a variety of rheumatologic, infectious, neuropsychiatric, and neurological symptoms. CFS patients have a significantly impaired functional status that leads to significant personal and economic complications. The purpose of this review was to determine if CBT is more successful than other treatments for CFS and whether it works for CBT both on its own and in conjunction with other therapies.

The review also examined the effectiveness of CBT in comparison to other psychological therapy modalities, such as counseling, support/education, and relaxation techniques. It concluded that patients receiving CBT had a higher likelihood of experiencing fewer symptoms of fatigue at the conclusion of their treatment than patients receiving other psychological therapies.

There was also a greater reduction in symptoms related to psychological distress, anxiety, depression, and physical functioning. The most compelling and reliable result is that those with CFS have greater rates of mental co-morbidity than healthy controls or disease control groups, primarily for anxiety and depressive disorders.


Keywords


ME/CFS, fatigue, chronic illness, cognitive behavioral therapy (CBT).

Full Text:

PDF

References


Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The Prevalence and Morbidity of Chronic Fatigue and Chronic Fatigue Syndrome: A Prospective Primary Care Study. Am J Public Health 1997;87:1449–1454.

Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J,Komaroff A. The Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;84:118–121.

Sharpe M, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, et al. A report—chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118–121.

Wessely S, Hotopf M, Sharpe M. Chronic Fatigue and Its Syndromes. New York: Oxford University Press, 1998.

Kroenke K,Wood DR, Mangelsdorff AD, Meier NJ, Powell JB. Chronic Fatigue in Primary Care: Prevalence, Patient Characteristics, and Outcome. J Am Med Assoc 1988;260:929–934.

Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and healthcare use. Med Care 1996;34:924–930.

Joyce J, Hotopf M, Wessely S. The Prognosis of chronic fatigue and fatigue syndrome: a systematic review. Q J Med 1997;90:223–233.

Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, K omaroff A: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953–959

Bombardier CH, Buchwald D: Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care 1996; 34:924–930

Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W: Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 1996; 101:364–370

Rowe, P.C.; Underhill, R.A.; Friedman, K.J.; Gurwitt, A.; Medow, M.S.; Schwartz, M.S.; Speight, N.;Stewart, J.M.; Vallings, R.; Rowe, K.S. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Front. Pediatr. 2017, 5, 121.

Bested, A.C.; Marshall, L.M. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An evidence-based approach to diagnosis and management by clinicians. Rev. Environ. Health 2015,30, 223–249.

Vermeulen, R.C.; Kurk, R.M.; Visser, F.C.; Sluiter,W.; Scholte, H.R. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. J. Transl. Med. 2010, 8, 93.

Clauw, D.J. Perspectives on fatigue from the study of chronic fatigue syndrome and related conditions. PM R 2010, 2, 414–430.

Cockshell, S.J.; Mathias, J.L. Cognitive functioning in chronic fatigue syndrome: Ameta-analysis. Psychol. Med.2010, 40, 1253–1267.

Pawlikowska T, Chalder T, Hirsch SR, Wallace P, Wright DJM, Wessely SC. Population-based study of fatigue and psychological distress. Br Med J 1994;308:763–766.

David A, Pelosi A, McDonald E, Stephewns D, Ledger D, Rathbone R, et al. Tired, weak or in need of rest: fatigue among general practice attenders. Br Med J 1990;301:1199–1202.

Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RK, et al. A community based study of chronic fatigue syndrome. Arch Intern Med 1999;159:2129–2137.

Cox B, Blaxter M, Buckle A. The Health and Lifestyle Survey. London: Health Promotion Research Trust, 1987.

Fuhrer R, Wessely S. Fatigue in French primary care. Psychol Med 1995;25:895–905.

Wessely S, Hotopf M, Sharpe M. Chronic Fatigue and its Syndromes. Oxford: Oxford University Press, 1998.

Farmer A, Jones I, Hillier J, Llewelyn M, Borysiewicz L, Smith A. Neurasthenia revisited: ICD-10 and DSM-III-R psychiatric symptoms in chronic fatigue patients and comparison subjects. Br J Psychiatry 1995;167:503–506.

Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003;65:528–533.

Skapinakis P, Lewis G, Mavoreas V. Unexplained fatigue syndromes in a multinational primary care sample: specificity of definition and prevalence and distinctiveness from depression and generalised anxiety. Am J Psychiatry 2003;160:785–787

Mueller C, Lin JC, Sheriff S, Maudsley AA,Younger JW. Evidence of widespread metabolite abnormalities inmyalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain ImagingBehav. 2019. doi:10.1007/s11682-018-0029-4

van Campen CLMC, Rowe PC, Visser FC. Blood volume status in ME/CFS correlates with the presence or absence of orthostatic symptoms: preliminary results. Front Pediatr. 2018;6:352. doi:10.3389/fped.2018.00352

Naviaux RK, Naviaux JC, Li K, et al. Metabolic features of chronic fatigue syndrome. Proc NatlAcad Sci U S A. 2016;113(37):E5472-E5480. doi:10.1073/pnas.1607571113.

Lloyd A, Hickie I, Brockman A, Dwyer J, Wakefield D. Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J Infect Dis. 1991;164:1023–4.

Natelson BH, Weaver SA, Tseng CL, Ottenweller JE. Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin Diagn Lab Immunol. 2005;12:52–5

Peterson D, Brenu EW, Gottschalk G, Ramos S. Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis. Mediators Inflamm. 2015;2015:929720

Hornig M, Gottschalk G, Peterson DL, Knox KK, Schultz AF, Eddy ML, Che X, Lipkin WI. Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. Mol Psychiatry. 2016;21:261–9.

Hornig M, Gottschalk CG, Eddy ML, Che X, Ukaigwe JE, Peterson DL, Lipkin WI. Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations. Transl Psychiatry. 2017;7:e1080.

King s Research Portal - King's College London. https://kclpure.kcl.ac.uk/portal/files/14675958/Lievesley_2014_CFS_Adolescents_ClinPsyReview_uncorrected_manuscript.pdf.

undefined. https://doi.org/10.1016/j.cpr.2014.02.002.

Reyes M, Gary HE Jr., Dobbins JG, et al. Surveillance for chronic fatigue syndrome—four U.S. cities, September 1989 though August 1993. MMWR CDC Surveill Summ. 1997;46(2):1-13.

Sharpe MC, Archard LC, Banatvala JE, et al. A report– chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991;84(2):118-121.

Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A; International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a compre¬hensive approach to its definition and study. Ann Intern Med. 1994;121(12):953-959.

National Collaborating Centre for Primary Care (Great Britain), Royal College of General Practitioners. Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Diagnosis and Management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy) in Adults and Children. London, England: National Collaborating Centre for Primary Care, Royal College of General Practitioners; 2007.

Mawle AC, Nisenbaum R, Dobbins JG, et al. Seroepi¬demiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis. 1995;21(6):1386-1389.

Whistler T, Jones JF, Unger ER, Vernon SD. Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol. 2005;5(1):5. 41. Zhang L, Gough J, Christmas D, et al. Microbial infec¬tions in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol. 2010;63(2):156-164.

Heim C, Nater UM, Maloney E, Boneva R, Jones JF, Reeves WC. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry. 2009;66(1):72-80.

Prins JB, Bos E, Huibers MJ, et al. Social support and the persistence of complaints in chronic fatigue syndrome. Psychother Psychosom. 2004;73(3):174-182.

Chalder T, Godfrey E, Ridsdale L, King M, Wessely S. Predictors of outcome in a fatigued population in pri¬mary care following a randomized controlled trial. Psychol Med. 2003;33(2):283-287.

Cevik R, Gur A, Acar S, Nas K, Sarac AJ. Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syn¬drome and effect of depressive mood on these hor¬mones. BMC Musculoskelet Disord. 2004;5:47. 46. Cleare AJ, Miell J, Heap E, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab. 2001;86(8):3545-3554.

van Heukelom RO, Prins JB, Smits MG, Bleijenberg G. Influence of melatonin on fatigue severity in patients with chronic fatigue syndrome and late melatonin secretion. Eur J Neurol. 2006;13(1):55-60.

Williams G, Waterhouse J, Mugarza J, Minors D, Hayden K. Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improve¬ment with melatonin or phototherapy. Eur J Clin Invest. 2002;32(11):831-837.

Maes M, Mihaylova I, Leunis JC. In chronic fatigue syn¬drome, the decreased levels of omega-3 poly-unsat¬urated fatty acids are related to lowered serum zinc and defects in T cell activation. Neuro Endocrinol Lett. 2005;26(6):745-751. 746 American Family Physician www.aafp.org/afp Volume 86, Number 8 ◆October 15, 2012

Brouwers FM, Van Der Werf S, Bleijenberg G, Van Der Zee L, Van Der Meer JW. The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind random¬ized controlled trial. QJM. 2002;95(10):677-683.

Price JR, Mitchell E, Tidy E, Hunot V. Cognitive behav¬iour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst Rev. 2008;(3):CD001027.

O’Dowd H, Gladwell P, Rogers CA, Hollinghurst S, Greg¬ory A. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpa¬tient group programme. Health Technol Assess. 2006; 10(37):iii-iv, ix-x, 1-121.

Deale A, Husain K, Chalder T, Wessely S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry. 2001;158(12):2038-2042.

Stulemeijer M, de Jong LW, Fiselier TJ, Hoogveld SW, Bleijenberg G. Cognitive behaviour therapy for ado¬lescents with chronic fatigue syndrome: randomised controlled trial [published correction appears in BMJ. 2005;330(7495):820]. BMJ. 2005;330(7481):14-21.

Nijhof SL, Bleijenberg G, Uiterwaal CS, Kimpen JL, van de Putte EM. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomized controlled trial. Lancet. 2012;379(9824):1412-1418.

Bazelmans E, Prins JB, Lulofs R, van der Meer JW, Bleijen¬berg G; Netherlands Fatigue Research Group Nijmegen. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study. Psychother Psychosom. 2005;74(4):218-224.

Knoop H, van der Meer JW, Bleijenberg G. Guided self-instructions for people with chronic fatigue syn¬drome: randomised controlled trial. Br J Psychiatry. 2008;193(4):340-341.

Powell P, Bentall RP, Nye FJ, Edwards RH. Patient edu¬cation to encourage graded exercise in chronic fatigue syndrome: 2-year follow-up of randomised controlled trial. Br J Psychiatry. 2004;184:142-146.

Moss-Morris R, Sharon C, Tobin R, Baldi JC. A random¬ized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol. 2005;10(2):245-259.

Wallman KE, Morton AR, Goodman C, Grove R, Guil¬foyle AM. Randomised controlled trial of graded exer¬cise in chronic fatigue syndrome. Med J Aust. 2004; 180(9):444-448.

Pardaens K, Haagdorens L, Van Wambeke P, Van den Broeck A, Van Houdenhove B. How relevant are exercise capacity measures for evaluating treatment effects in chronic fatigue syndrome? Results from a prospective, multidisciplinary outcome study. Clin Rehabil. 2006; 20(1):56-66.

Wearden AJ, Dowrick C, Chew-Graham C, et al; Fatigue Intervention by Nurses Evaluation (FINE) Trial Writing Group and the FINE Trial Group. Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. BMJ. 2010;340:c1777.

Bentall RP, Powell P, Nye FJ, Edwards RH. Predictors of response to treatment for chronic fatigue syndrome. Br J Psychiatry. 2002;181:248-252.

Weatherley-Jones E, Nicholl JP, Thomas KJ, et al. A ran¬domised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. J Psychosom Res. 2004;56(2):189-197. 65. Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, Montoya JG. Use of valganciclovir in patients with elevated antibody titers against human herpesvirus-6 (HHV-6) and Epstein-Barr virus (EBV) who were experiencing central nervous system dys¬function including long-standing fatigue. J Clin Virol. 2006;37(suppl 1):S33-S38.

Blockmans D, Persoons P, Van Houdenhove B, Lejeune M, Bobbaers H. Combination therapy with hydrocorti¬sone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Am J Med. 2003;114(9):736-741.

Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, Gottfries CG. Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome–a ran¬domised controlled trial. Eur J Pain. 2002;6(6):455-466.

Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med. 2006;119(2):167. e23-167.e30.

Hartz AJ, Bentler SE, Brake KA, Kelly MW. The effective¬ness of citalopram for idiopathic chronic fatigue. J Clin Psychiatry. 2003;64(8):927-935.

Blacker CV, Greenwood DT, Wesnes KA, et al. Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. JAMA. 2004;292(10): 1195-1204.

What is Chronic fatigue syndrome and its possible symptoms, causes, risk and prevention methods?. https://www.msn.com/en-us/health/condition/Chronic-fatigue-syndrome/hp-Chronic-fatigue-syndrome?source=conditioncdx.

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). https://www.mayoclinic.org/diseases-conditions/chronic-fatigue-syndrome/symptoms-causes/syc-20360490.

Chronic Fatigue Syndrome Prognosis - News-Medical.net. https://www.news-medical.net/health/Chronic-Fatigue-Syndrome-Prognosis.aspx.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). https://my.clevelandclinic.org/health/diseases/17720-myalgic-encephalomyelitis-chronic-fatigue-syndrome-me-cfs.

undefined. http://www.cdc.gov/cfs/pdf/cfs-toolkit.pdf.

undefined. http://www.cfids-cab.org/MESA/me_overview.pdf.

undefined. http://www.nice.org.uk/nicemedia/live/11824/36191/36191.pdf.

undefined. http://www.ncf-net.org/patents/pdf/Fukuda_Definition.pdf.

undefined. https://laskerfoundation.org.

undefined. https://www.iacfsme.org/.

Jonathan R Price, Edward Mitchell, Elizabeth Tidy, Viven Hunot. Cognitive behaviour therapy for chronic fatigue syndrome in adults: 16 July 2008 : https://doi.org/10.1002/14651858.CD001027.pub2 82. “Emerging Options for Autoimmune ME/CFS ... - Health Rising. https://www.healthrising.org/blog/2021/09/16/autoimmune-options-chronic-fatigue-syndrome-scheibenbogen/.

Researchers discover potential therapeutic approach to treat chronic .... https://medicalxpress.com/news/2019-11-potential-therapeutic-approach-chronic-fatigue.html.

Chronic Fatigue Syndrome: Causes & Treatments - Life Extension. https://www.lifeextension.com/protocols/immune-connective-joint/chronic-fatigue.

Evidence-Based Care for People with Chronic Fatigue Syndrome and .... https://link.springer.com/article/10.1007/s11606-021-07188-4.

Treatments of chronic fatigue syndrome and its debilitating .... https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03461-0. 87. Smith, M. E., Bateman, L., Rowe, P. K., & Edwards, J. K. (2013). Graded exercise therapy for chronic fatigue syndrome: A systematic review and meta-analysis. Clinical Journal of Sport Medicine, 23(6), 435-443.

Vickers, A. J., Straus, K. L., Landers, G., Riley, D., Stevinson, C., & Meade, T. W. (2003). Acupuncture for chronic fatigue syndrome: A systematic review. Journal of the American Medical Association, 290(3), 393-405.

Richardson, D. P., & Montgomery, S. A. (2003). Coenzyme Q10 for chronic fatigue syndrome. Cochrane Database of Systematic Reviews, (3), CD003914.

Garcia-Vidal, C., & Anderson, D. D. (2013). Stem cell therapy for chronic fatigue syndrome: A review. Expert Opinion on Biological Therapy, 13(11), 1599-1612.

A review of the predisposing, precipitating and perpetuating factors in .... https://psycnet.apa.org/record/2014-13191-006.

The Role of Perfectionism in Chronic Fatigue Syndrome. https://link.springer.com/chapter/10.1007/978-3-319-18582-8_5.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Research & Reviews: A Journal of Drug Design & Discovery